1. Home
  2. ABCL vs TTGT Comparison

ABCL vs TTGT Comparison

Compare ABCL & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • TTGT
  • Stock Information
  • Founded
  • ABCL 2012
  • TTGT 1999
  • Country
  • ABCL Canada
  • TTGT United States
  • Employees
  • ABCL N/A
  • TTGT N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • TTGT Telecommunications Equipment
  • Sector
  • ABCL Health Care
  • TTGT Telecommunications
  • Exchange
  • ABCL Nasdaq
  • TTGT Nasdaq
  • Market Cap
  • ABCL 818.2M
  • TTGT 961.8M
  • IPO Year
  • ABCL 2020
  • TTGT 2007
  • Fundamental
  • Price
  • ABCL $2.23
  • TTGT $14.81
  • Analyst Decision
  • ABCL Buy
  • TTGT Buy
  • Analyst Count
  • ABCL 3
  • TTGT 7
  • Target Price
  • ABCL $7.00
  • TTGT $28.00
  • AVG Volume (30 Days)
  • ABCL 3.8M
  • TTGT 220.0K
  • Earning Date
  • ABCL 05-06-2025
  • TTGT 03-31-2025
  • Dividend Yield
  • ABCL N/A
  • TTGT N/A
  • EPS Growth
  • ABCL N/A
  • TTGT N/A
  • EPS
  • ABCL N/A
  • TTGT N/A
  • Revenue
  • ABCL $28,833,000.00
  • TTGT $260,750,999.00
  • Revenue This Year
  • ABCL N/A
  • TTGT $26.95
  • Revenue Next Year
  • ABCL $27.77
  • TTGT N/A
  • P/E Ratio
  • ABCL N/A
  • TTGT N/A
  • Revenue Growth
  • ABCL N/A
  • TTGT 31.84
  • 52 Week Low
  • ABCL $2.11
  • TTGT $13.04
  • 52 Week High
  • ABCL $4.75
  • TTGT $35.10
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 36.73
  • TTGT 49.90
  • Support Level
  • ABCL $2.32
  • TTGT $14.48
  • Resistance Level
  • ABCL $2.60
  • TTGT $15.39
  • Average True Range (ATR)
  • ABCL 0.13
  • TTGT 0.88
  • MACD
  • ABCL 0.01
  • TTGT 0.21
  • Stochastic Oscillator
  • ABCL 13.95
  • TTGT 70.52

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About TTGT TechTarget Inc.

TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.

Share on Social Networks: